| Fund ID | 805-2405882018 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 100% |
| Owned by the adviser or related persons | 2% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 0% |
| Fund | Type | Gross assets |
|---|---|---|
| Innovatus Life Sciences Offshore Fund I-A, LP | Private Equity | $205.4M |
| Innovatus Flagship Fund I, LP | Private Equity | $116.9M |
| Innovatus Emirates Offshore Fund I, LP | Private Equity | $111.9M |
Innovatus Life Sciences Lending Fund I, LP reports $368.7 million in gross assets, among the top 20% of private funds by size.
The stated minimum investment is $2 million.
Innovatus Life Sciences Lending Fund I, LP is managed by Innovatus Capital Partners, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.